Jacob M. Rowe

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Marilyn L. Slovak, Kenneth J. Kopecky, Peter A. Cassileth et al. · Blood · 2000 · 1.6K citations

Medicine, Hematology, Oncology +10

All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic Leukemia

Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer et al. · New England Journal of Medicine · 1997 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +11

Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

Peter A. Cassileth, David P. Harrington, Frederick R. Appelbaum et al. · New England Journal of Medicine · 1998 · 609 citations · Full text

Medicine, Oncology, Chemotherapy +13

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

Jae H. Park, Baozhen Qiao, Katherine S. Panageas et al. · Blood · 2011 · 420 citations · Full text

Life Sciences, Hematology, Oncology +11

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710

Bayard L. Powell, Barry Kurt Moser, Wendy Stock et al. · Blood · 2010 · 399 citations · Full text

Medicine, Hematology, Oncology +12